. Aide-mémoire-n°310 and . Who, Principales causes de mortalité dans le monde Disponible sur internet, 2013.

T. Lambert, Déficiences et maladies invalidantes: 468 000 personnes touchées par an. La lettre des études de l'AGEFIPH, 2007.

G. Lagrue and A. Maurel, Tabagisme et maladies vasculaires. EMC -Angéiologie, 2010.
DOI : 10.1016/s1290-0176(10)71331-4

D. Thomas, B??n??fices cardiovasculaires du sevrage tabagique, La Presse M??dicale, vol.38, issue.6, pp.946-52, 2009.
DOI : 10.1016/j.lpm.2009.02.009

G. Nalbone, Pollution par les particules atmosph??riques fines et ultrafines et risque cardiovasculaire, M??decine & Long??vit??, vol.2, issue.1, pp.22-39, 2010.
DOI : 10.1016/j.mlong.2009.10.006

C. Caulin and S. Vidal, Vidal Recos : recommandations en pratique, 2014 175 stratégies thérapeutiques. 5e édition. Issy-les-Moulineaux: Vidal; 2013. Consultation sur internet via compte personnel sur www

K. Ried, O. Frank, N. Stocks, P. Fakler, and T. Sullivan, Effect of garlic on blood pressure: A systematic review and meta-analysis, BMC Cardiovascular Disorders, vol.354, issue.16, p.13, 2008.
DOI : 10.1056/NEJMoa060838

K. Reinhart, R. Talati, C. White, and C. Coleman, The impact of garlic on lipid parameters: a systematic review and meta-analysis, Nutrition Research Reviews, vol.17, issue.01, pp.39-48, 2009.
DOI : 10.1016/S0952-3278(98)90034-5

B. Olson, S. Anderson, M. Becker, J. Anderson, D. Hunninghake et al., Psyllium-enriched cereals lower blood total cholesterol and LDL cholesterol, but not HDL cholesterol, in hypercholesterolemic adults: results of a meta-analysis, J Nutr, vol.127, pp.1973-80, 1997.

S. Mendis, P. Puska, and B. Norrving, World Health Organization en collaboration avec la World Heart Federation et la World Stroke Organization. Global Atlas on cardiovascular disease prevention and control Disponible sur internet, 2011.

C. Mathers and D. Loncar, Projections of global mortality and burden of disease from, PLOS Med, vol.3, issue.11, pp.2011-2041, 2002.

H. Tunstall-pedoe, K. Kuulasmaa, M. Mähönen, H. Tolonen, E. Ruokokoski et al., Contribution of trends in survival and coronar y-event rates to changes in coronary heart disease mortality: 10-year results from 37 WHO MONICA Project populations, The Lancet, vol.353, issue.9164, pp.1547-57, 1999.
DOI : 10.1016/S0140-6736(99)04021-0

A. Wagner, D. Arveiler, J. Ruidavets, D. Cottel, V. Bongard et al., État des lieux sur l'hypertension artérielle en France en 2007: l'étude Mona Lisa, Bull. Epidemiol. Hebd, vol.49, pp.483-489, 2008.

H. Ait-oufella, Z. Mallat, and A. Tedgui, Physiopathologie de l'athérosclérose. Encyclopédie médico-chirurgicale, 2013.

J. Toussaint and V. Fuster, Société française d'athérosclérose. L'athérosclérose : physiopathologie, diagnostics, thérapeutiques, p.776, 2003.

. Ameli-santé, le site d'information santé de l'Assurance Maladie. L'infarctus du myocarde. 2013. Disponible sur internet, 2014.

P. Meneton, J. Ménard, A. Bourget-massari, C. Point, and P. Truffe-bonnal, Direction générale de la Santé. PROGRAMME NATIONAL NUTRITION-SANTE. Hypertension Arterielle, alimentation et mode de vie, 2006.

R. Haïat, G. Leroy, and D. Thomas, Facteurs de risque cardiovasculaire. Paris: Frison- Roche, p.146, 2007.

. Ministère-du-travail, . Emploi, . De, and . Santé, Programme national nutrition santé Disponible sur internet http, 2011.

J. Ferrières, V. Bongard, J. Dallongeville, D. Arveiler, D. Cottel et al., Trends in plasma lipids, lipoproteins and dyslipidaemias in French adults, 1996???2007, Archives of Cardiovascular Diseases, vol.102, issue.4, pp.293-301, 1996.
DOI : 10.1016/j.acvd.2009.02.002

R. Goldenberg and Z. Punthakee, Canadian Diabetes Association Clinical Practice Guidelines Expert Committee. Definition, Classification and Diagnosis of Diabetes, Prediabetes and Metabolic Syndrome. Can, J. Diabetes, vol.37, pp.8-11, 2013.

F. Beck, R. Guignard, J. Richard, J. Wilquin, and P. Peretti-watel, Premiers résultats du baromètre santé 2010 Evolutions récentes du tabagisme en France

N. Benowitz, Drug therapy Pharmacologic aspects of cigarette smoking and nicotine addition, N. Engl. J. Med, vol.319, pp.1318-1348, 1988.

K. Teo, S. Ounpuu, S. Hawken, M. Pandey, V. Valentin et al., Tobacco use and risk of myocardial infarction in 52 countries in the INTERHEART study: a case-control study, The Lancet, vol.368, issue.9536, pp.647-58, 2006.
DOI : 10.1016/S0140-6736(06)69249-0

J. Powell and R. Greenhalgh, Smoking and factors influencing the outcome of arterial reconstruction, Ann. Chir. Gynaecol, vol.81, pp.236-277, 1992.

P. Priollet, J. Mourad, P. Cacoub, H. Lévesque, F. Luizy et al., L???art??riopathie des membres inf??rieurs en m??decine g??n??rale. Quelle prise en charge ?, Journal des Maladies Vasculaires, vol.29, issue.5, pp.249-254, 2004.
DOI : 10.1016/S0398-0499(04)96769-8

M. Sauvanier, J. Constans, S. Skopinski, D. Barcat, A. Berard et al., Les artériopathies des membres inférieurs débutant avant 50 ans Disponible sur internet, 2008.

R. Shinton and G. Beevers, Meta-analysis of relation between cigarette smoking and stroke., BMJ, vol.298, issue.6676, pp.789-94, 1989.
DOI : 10.1136/bmj.298.6676.789

L. Foubert, Hyperlipidémies et pilule contraceptive, Sang Thromb Vaiss, vol.11, pp.761-766, 1999.

R. Koeth, Z. Wang, B. Levison, J. Buffa, E. Org et al., Intestinal microbiota metabolism of l-carnitine, a nutrient in red meat, promotes atherosclerosis, Nature Medicine, vol.129, issue.5, pp.576-85, 2013.
DOI : 10.1007/s001840200192

Z. Wang, E. Klipfell, B. Bennett, R. Koeth, B. Levison et al., Gut flora metabolism of phosphatidylcholine promotes cardiovascular disease, Nature, vol.53, issue.7341, pp.57-63, 2011.
DOI : 10.1038/nature09922

L. Roy, T. Doré, J. Gérard, and P. , Microbiote et athérosclérose. Identification d'un nouveau facteur environnemental, Diabète Obésité, vol.8, p.79, 2013.

L. Bureau, Veille r??glementaire ??? Synth??se et commentaires, Phytoth??rapie, vol.6, issue.5, pp.312-317, 2008.
DOI : 10.1007/s10298-008-0338-7

. Sénat, Proposition de loi visant à créer un diplôme et organiser la profession d'herboriste, Disponible sur internet, 2011.

/. Ce, D. Parlement, and . Et, 31 mars 2004 modifiant, en ce qui concerne les médicaments traditionnels à base de plantes, la directiveCE instituant un code communautaire relatif aux médicaments à usage humain. 30 Avril Disponible sur internet : http://eurlex World Health Organization. WHO Monographs on Selected Medicinal Plants. World Health Organization, p.572, 1999.

C. Silagy and H. Neil, A meta-analysis of the effect of garlic on blood pressure, Journal of Hypertension, vol.12, issue.4, pp.463-471, 1994.
DOI : 10.1097/00004872-199404000-00017

S. Mirunalini, M. Krishnaveni, and V. Ambily, Effects of raw garlic (Allium sativum L.) on hyperglycemia in patients with type 2 diabetes mellitus, Pharmacologyonline, vol.2, pp.968-74, 2011.

R. Kumar, S. Chhatwal, S. Arora, S. Sharma, J. Singh et al., Antihyperglycemic, antihyperlipidemic, anti-inflammatory and adenosine deaminase–lowering effects of garlic in patients with type 2 diabetes mellitus with obesity, Diabetes, Metabolic Syndrome and Obesity: Targets and Therapy, vol.6, pp.49-56, 2013.
DOI : 10.2147/DMSO.S38888

6. I. Le-curcuma, Disponible sur internet (adhérents seulement): http://www.iesv.org/ (Dernière consultation, 2014.

S. Chuengsamarn, S. Rattanamongkolgul, B. Phonrat, R. Tungtrongchitr, and S. Jirawatnotai, Reduction of atherogenic risk in patients with type 2 diabetes by curcuminoid extract: a randomized controlled trial, The Journal of Nutritional Biochemistry, vol.25, issue.2, pp.144-50, 2014.
DOI : 10.1016/j.jnutbio.2013.09.013

E. Sukandar, P. Sudjana, J. Sigit, N. Leliqia, and F. Lestari, Safety of Garlic (Allium Sativum) and Turmeric (Curcuma domestica) Extract in Comparison with Simvastatin on Improving Lipid Profile in Dyslipidemia Patients, Journal of Medical Sciences(Faisalabad), vol.13, issue.1, pp.10-18, 2013.
DOI : 10.3923/jms.2013.10.18

E. Sukandar, H. Permana, I. Adnyana, J. Sigit, R. Ilyas et al., Clinical Study of Turmeric (Curcuma longa L.) and Garlic (Allium sativum L.) Extracts as Antihyperglycemic and Antihyperlipidemic Agent in Type-2 Diabetes-Dyslipidemia Patients, International Journal of Pharmacology, vol.6, issue.4, pp.438-483, 2010.
DOI : 10.3923/ijp.2010.456.463

M. Dr and . Rombi, 100 plantes médicinales. Composition, mode d'action et intérêt thérapeutique 2e édition, 1999.

J. Raynaud and J. Blanchet, Prescription et conseil en phytothérapie, Éditions Tec & Doc Éditions Médicales, 2005.

C. On and . Medicinal, Assessment report on Olea europaea L., folium European Medicines Agency Disponible sur internet : http://www.emea.europa.eu 72. COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC) Community herbal monograph on Olea europaea L., folium. European Medicines Agency, Disponible sur internet, 2011.

I. L. Olivier, Disponible sur internet (adhérents seulement): http://www.iesv.org/media/mono-olivier.pdf (Dernière consultation, 2014.

T. Perrinjaquet-moccetti, A. Busjahn, C. Schmidlin, A. Schmidt, B. Bradl et al., L.) leaf extract reduces blood pressure in borderline hypertensive monozygotic twins, Phytotherapy Research, vol.57, issue.9, pp.1239-1281, 2008.
DOI : 10.1002/ptr.2455

E. Susalit, N. Agus, I. Effendi, R. Tjandrawinata, D. Nofiarny et al., Olive (Olea europaea) leaf extract effective in patients with stage-1 hypertension: Comparison with Captopril, Phytomedicine, vol.18, issue.4, pp.251-259, 2011.
DOI : 10.1016/j.phymed.2010.08.016

D. Bock, M. Derraik, J. Brennan, C. Biggs, J. Morgan et al., Olive (Olea europaea L.) Leaf Polyphenols Improve Insulin Sensitivity in Middle-Aged Overweight Men: A Randomized, Placebo-Controlled, Crossover Trial, PLoS ONE, vol.18, issue.3, p.57622, 2013.
DOI : 10.1371/journal.pone.0057622.s002

M. Pittler, R. Guo, and E. Ernst, Hawthorn extract for treating chronic heart failure, Cochrane Database Syst Rev, vol.34, issue.1, 2008.
DOI : 10.1002/14651858.CD005312

S. Ghosh, V. Kapil, I. Fuentes-calvo, K. Bubb, V. Pearl et al., Enhanced Vasodilator Activity of Nitrite in Hypertension: Critical Role for Erythrocytic Xanthine Oxidoreductase and Translational Potential, Hypertension, vol.61, issue.5, pp.1091-102, 2013.
DOI : 10.1161/HYPERTENSIONAHA.111.00933

J. Stoclet and V. Schini-kerth, Flavono??des alimentaires et sant?? humaine, Annales Pharmaceutiques Fran??aises, vol.69, issue.2, pp.78-90, 2011.
DOI : 10.1016/j.pharma.2010.11.004

L. «. Drouet, ????La m??decine bas??e sur les preuves peut-elle d??boucher sur deux avis contradictoires??????? Le vin??: un toxique??? Ou existe-t-il un b??n??fice, en particulier cardiovasculaire, ?? une consommation r??guli??re et mod??r??e???, Journal des Maladies Vasculaires, vol.34, issue.4, pp.249-52, 2009.
DOI : 10.1016/j.jmv.2009.05.001

K. Ried, T. Sullivan, P. Fakler, O. Frank, and N. Stocks, Effect of cocoa on blood pressure, Cochrane Database Syst Rev, vol.8, issue.7, 2012.
DOI : 10.1002/14651858.CD008893.pub2

L. Hartley, N. Flowers, J. Holmes, A. Clarke, S. Stranges et al., Green and black tea for the primary prevention of cardiovascular disease. Cochrane Database Syst Rev, 2013.

V. Collomb and M. Mayor, Le soja, la reine des légumineuses ? [Internet] Haute école de santé de Genève, Disponible sur internet, 2007.

. Webmd-better-information, Better health

U. Müller, W. Weber, A. Hoffmann, S. Franke, R. Lange et al., Commercial soybean lecithins: a source of hidden allergens?, Zeitschrift f???r Lebensmitteluntersuchung und -Forschung A, vol.207, issue.5, pp.341-51, 1998.
DOI : 10.1007/s002170050343

H. Awazuhara, H. Kawai, M. Baba, T. Matsui, and A. Komiyama, Antigenicity of the proteins in soy lecithin and soy oil in soybean allergy, Clinical <html_ent glyph="@amp;" ascii="&"/> Experimental Allergy, vol.227, issue.12, pp.1559-64, 1998.
DOI : 10.1016/0091-6749(85)90709-2

M. Behr, J. Oehlmann, and M. Wagner, Estrogens in the daily diet: In vitro analysis indicates that estrogenic activity is omnipresent in foodstuff and infant formula, Food and Chemical Toxicology, vol.49, issue.10, pp.2681-2689, 2011.
DOI : 10.1016/j.fct.2011.07.039

A. Mourad, E. De-carvalho-pincinato, P. Mazzola, M. Sabha, and P. Moriel, Influence of Soy Lecithin Administration on Hypercholesterolemia, Cholesterol, vol.131, issue.9, p.824813, 2010.
DOI : 10.1016/j.jnutbio.2005.11.005

J. Bruneton, Phytothérapie : les données de l'évaluation. Paris: Éd. Tec & doc, p.242, 2012.

. Eurekasante, . Fr, and . Vidal, Protéines de soja Disponible sur internet : http://www.eurekasante.fr/parapharmacie/complements-alimentaires/proteinessoja .html (Dernière consultation, 2014.

J. Anderson, B. Johnstone, and M. Cook-newell, Meta-Analysis of the Effects of Soy Protein Intake on Serum Lipids, New England Journal of Medicine, vol.333, issue.5, pp.276-82, 1995.
DOI : 10.1056/NEJM199508033330502

F. Sacks, A. Lichtenstein, L. Horn, W. Harris, P. Kris-etherton et al., Soy Protein, Isoflavones, and Cardiovascular Health: An American Heart Association Science Advisory for Professionals From the Nutrition Committee, Circulation, vol.113, issue.7, pp.1034-1078, 2006.
DOI : 10.1161/CIRCULATIONAHA.106.171052

K. Taku, K. Umegaki, Y. Ishimi, and S. Watanabe, Effects of extracted soy isoflavones alone on blood total and LDL cholesterol: Meta-analysis of randomized controlled trials, Therapeutics and Clinical Risk Management, vol.4, pp.1097-103, 2008.
DOI : 10.2147/TCRM.S3262

C. Xiao, Health Effects of Soy Protein and Isoflavones in Humans, J. Nutr, vol.138, pp.1244-1249, 2008.

B. Wider, M. Pittler, J. Thompson-coon, and E. Ernst, Artichoke leaf extract for treating hypercholesterolaemia, Cochrane Database Syst Rev, 2013.

C. On, . Medicinal, and . Products, Final Community herbal monograph on Plantago ovata Forssk., seminis tegumentum European Medicines Agency, Disponible sur internet

Z. Wei, H. Wang, X. Chen, B. Wang, Z. Rong et al., Time- and dose-dependent effect of psyllium on serum lipids in mild-to-moderate hypercholesterolemia: a meta-analysis of controlled clinical trials, European Journal of Clinical Nutrition, vol.307, issue.7, pp.821-828, 2009.
DOI : 10.1111/j.1365-277X.1994.tb00423.x

C. Government and . Hc, Psyllium Products and Blood Cholesterol Lowering - Nutrition and Health Claims -Food Labelling -Health Canada Disponible sur internet: http://www.hc-sc.gc.ca/fn-an/label-etiquet/claims-reclam/assessevalu/psyllium-cholesterol-eng .php 107. COMMITTEE ON HERBAL MEDICINAL PRODUCTS (HMPC). Final assessment report on Plantago ovata Forssk., seminis tegumentum, European Medicines, 2011.

M. Hall and T. Flinkman, Do Fiber and Psyllium Fiber Improve Diabetic Metabolism?, The Consultant Pharmacist, vol.27, issue.7, pp.513-519, 2012.
DOI : 10.4140/TCP.n.2012.513

L. Brown, B. Rosner, W. Willett, and F. Sacks, Cholesterol-lowering effects of dietary fiber: a meta-analysis. Am, J. Clin. Nutr, vol.69, pp.30-42, 1999.

M. Prasanna, Hypolipidemic effect of fenugreek: A clinical study, Indian J. Pharmacol, vol.32, pp.34-40, 2000.

N. Neelakantan, M. Narayanan, R. De-souza, and R. Van-dam, Effect of fenugreek (Trigonella foenum-graecumL.) intake on glycemia: a meta-analysis of clinical trials, Nutrition Journal, vol.32, issue.1, p.7, 2014.
DOI : 10.1111/j.1463-1326.2012.01603.x

C. Ollier, Le conseil en phytothérapie. 2e édition. Rueil-Malmaison: Éd. Pro-officina, 2011.

A. Goldberg, O. Jr, R. Bateman, J. Schimmoeller, L. Mcpherson et al., Effect of Plant Stanol Tablets on Low-Density Lipoprotein Cholesterol Lowering in Patients on Statin Drugs, The American Journal of Cardiology, vol.97, issue.3, pp.376-385, 2006.
DOI : 10.1016/j.amjcard.2005.08.056